Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation.

Bögeholz J, Russkamp NF, Wilk CM, Gourri E, Haralambieva E, Schanz U, Mueller NJ, Manz MG, Müller AMS.

Biol Blood Marrow Transplant. 2019 Nov 1. pii: S1083-8791(19)30709-8. doi: 10.1016/j.bbmt.2019.10.027. [Epub ahead of print]

PMID:
31682977
2.

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.

Zhu Y, Weiss T, Zhang Q, Sun R, Wang B, Yi X, Wu Z, Gao H, Cai X, Ruan G, Zhu T, Xu C, Lou S, Yu X, Gillet L, Blattmann P, Saba K, Fankhauser CD, Schmid MB, Rutishauser D, Ljubicic J, Christiansen A, Fritz C, Rupp NJ, Poyet C, Rushing E, Weller M, Roth P, Haralambieva E, Hofer S, Chen C, Jochum W, Gao X, Teng X, Chen L, Zhong Q, Wild PJ, Aebersold R, Guo T.

Mol Oncol. 2019 Nov;13(11):2305-2328. doi: 10.1002/1878-0261.12570. Epub 2019 Sep 18.

3.

Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.

Doerschner M, Pekar-Lukacs A, Messerli-Odermatt O, Dommann-Scherrer C, Rütti M, Müller AM, Nair G, Kamarachev J, Kerl K, Beer M, Messerli M, Frauenknecht K, Haralambieva E, Hoetzenecker W, French LE, Guenova E.

Br J Dermatol. 2019 Dec;181(6):1296-1302. doi: 10.1111/bjd.17535. Epub 2019 Mar 4.

PMID:
30565216
4.

A 72-year old female with multiple supra- and infratentorial dural masses.

Kirschenbaum D, Woernle C, Haralambieva E, Marques Maggio E, Bernays R, Camenisch U, Rushing EJ.

Brain Pathol. 2018 Nov;28(6):1023-1024. doi: 10.1111/bpa.12666. No abstract available.

PMID:
30536772
5.

Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.

Simonis A, Fux M, Nair G, Mueller NJ, Haralambieva E, Pabst T, Pachlopnik Schmid J, Schmidt A, Schanz U, Manz MG, Müller AMS.

Ann Hematol. 2018 Oct;97(10):1961-1973. doi: 10.1007/s00277-018-3388-4. Epub 2018 Jun 13. Review.

PMID:
29947977
6.

Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study.

Brüggen MC, Kerl K, Haralambieva E, Schanz U, Chang YT, Ignatova D, Dummer R, Cozzio A, Hoetzenecker W, French LE, Guenova E.

Acta Derm Venereol. 2018 Oct 10;98(9):835-841. doi: 10.2340/00015555-2950.

7.

Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome.

Vavassori S, Galson JD, Trück J, van den Berg A, Tamminga RYJ, Magerus-Chatinet A, Pellé O, Camenisch Gross U, Marques Maggio E, Prader S, Opitz L, Nüesch U, Mauracher A, Volkmer B, Speer O, Suda L, Röthlisberger B, Zimmermann DR, Müller R, Diepstra A, Visser L, Haralambieva E, Neven B, Rieux-Laucat F, Pachlopnik Schmid J.

Blood Adv. 2017 Jun 22;1(15):1101-1106. doi: 10.1182/bloodadvances.2017006411. eCollection 2017 Jun 27.

8.

Fibrin-associated diffuse large B-cell lymphoma in a hemorrhagic cranial arachnoid cyst.

Kirschenbaum D, Prömmel P, Vasella F, Haralambieva E, Marques Maggio E, Reisch R, Beer M, Camenisch U, Rushing EJ.

Acta Neuropathol Commun. 2017 Aug 7;5(1):60. doi: 10.1186/s40478-017-0463-3. No abstract available.

9.

Orbital Pseudotumor as a Rare Extrahepatic Manifestation of Hepatitis C Infection.

Misselwitz B, Epprecht J, Mertens J, Biedermann L, Scharl M, Haralambieva E, Lutterotti A, Weber KP, Müllhaupt B, Chaloupka K.

Case Rep Gastroenterol. 2016 May 19;10(1):108-14. doi: 10.1159/000444011. eCollection 2016 Jan-Apr.

10.

Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.

Valera A, Epistolio S, Colomo L, Riva A, Balagué O, Dlouhy I, Tzankov A, Bühler M, Haralambieva E, Campo E, Soldini D, Mazzucchelli L, Martin V.

Mod Pathol. 2016 Aug;29(8):844-53. doi: 10.1038/modpathol.2016.71. Epub 2016 Apr 29.

11.

Biological Relevance and Therapeutic Potential of the Hypusine Modification System.

Pällmann N, Braig M, Sievert H, Preukschas M, Hermans-Borgmeyer I, Schweizer M, Nagel CH, Neumann M, Wild P, Haralambieva E, Hagel C, Bokemeyer C, Hauber J, Balabanov S.

J Biol Chem. 2015 Jul 24;290(30):18343-60. doi: 10.1074/jbc.M115.664490. Epub 2015 Jun 2.

12.

Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.

Mehra T, Ikenberg K, Moos RM, Benz R, Nair G, Schanz U, Haralambieva E, Hoetzenecker W, Dummer R, French LE, Guenova E, Cozzio A.

JAMA Dermatol. 2015 Jan;151(1):73-7. doi: 10.1001/jamadermatol.2014.1629.

PMID:
25317818
13.

Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.

Patel S, Murphy D, Haralambieva E, Abdulla ZA, Wong KK, Chen H, Gould E, Roncador G, Hatton C, Anderson AP, Banham AH, Pulford K.

Biomark Insights. 2014 Sep 3;9:77-84. doi: 10.4137/BMI.S16553. eCollection 2014.

14.

Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

Rouhigharabaei L, Finalet Ferreiro J, Tousseyn T, van der Krogt JA, Put N, Haralambieva E, Graux C, Maes B, Vicente C, Vandenberghe P, Cools J, Wlodarska I.

PLoS One. 2014 Jan 9;9(1):e85851. doi: 10.1371/journal.pone.0085851. eCollection 2014.

15.

BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.

Camicia R, Bachmann SB, Winkler HC, Beer M, Tinguely M, Haralambieva E, Hassa PO.

J Cell Sci. 2013 May 1;126(Pt 9):1969-80. doi: 10.1242/jcs.118174. Epub 2013 Mar 13.

16.

[Oral metastasis of a renal cell carcinoma. A case report concerning the first manifestation of a renal cell carcinoma as bone metastasis in the mandible].

Wittig J, Bredell MG, Kruse A, Haralambieva E, Grätz KW, Lübbers HT.

Schweiz Monatsschr Zahnmed. 2012;122(7-8):619-27. French, German.

17.

RNASET2--an autoantigen in anaplastic large cell lymphoma identified by protein array analysis.

Patel S, Chen H, Monti L, Gould E, Haralambieva E, Schmid J, Toomey D, Woessmann W, Roncador G, Hatton CS, Liggins AP, Taramelli R, Banham AH, Acquati F, Murphy D, Pulford K.

J Proteomics. 2012 Sep 18;75(17):5279-92. doi: 10.1016/j.jprot.2012.06.009. Epub 2012 Jun 23.

PMID:
22732457
18.

Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases.

Rasche L, Bernard C, Topp MS, Kapp M, Duell J, Wesemeier C, Haralambieva E, Maeder U, Einsele H, Knop S.

Ann Hematol. 2012 Jul;91(7):1031-7. doi: 10.1007/s00277-012-1414-5.

PMID:
22286070
19.

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.

Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernández L, Rosenwald A.

Blood. 2011 Nov 17;118(20):5550-8. doi: 10.1182/blood-2011-06-361972. Epub 2011 Sep 29.

20.

FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.

Hoeller S, Schneider A, Haralambieva E, Dirnhofer S, Tzankov A.

Histopathology. 2010 Jul;57(1):73-80. doi: 10.1111/j.1365-2559.2010.03600.x. Epub 2010 Jun 23.

PMID:
20579129

Supplemental Content

Loading ...
Support Center